C
Christopher W. Calabria
Researcher at Wilford Hall Medical Center
Publications - 29
Citations - 1507
Christopher W. Calabria is an academic researcher from Wilford Hall Medical Center. The author has contributed to research in topics: Allergen immunotherapy & Allergy. The author has an hindex of 13, co-authored 27 publications receiving 1331 citations.
Papers
More filters
Journal ArticleDOI
Allergen immunotherapy: A practice parameter third update
Linda Cox,Harold S. Nelson,Richard F. Lockey,Christopher W. Calabria,Thomas Chacko,Ira Finegold,M.R. Nelson,Richard W. Weber,David I. Bernstein,Joann Blessing-Moore,David A. Khan,David M. Lang,Richard A. Nicklas,John Oppenheimer,Jay M. Portnoy,Christopher Randolph,Diane E. Schuller,Sheldon L. Spector,Stephen A. Tilles,Dana Wallace +19 more
TL;DR: These parameters were developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the American Col- lege of Allergen,Asthma & immunology (ACAAI); and the Joint Council of All allergy, asthma, and Immunology.
Journal ArticleDOI
Comparison of serum-specific IgE (ImmunoCAP) and skin-prick test results for 53 inhalant allergens in patients with chronic rhinitis.
TL;DR: In patients with a total IgE level > or = 200 IU/L, the percentage of positive CAP results for 52/53 allergens was significantly higher with more CAP+ST- results.
Journal ArticleDOI
Local production of IgE in the respiratory mucosa and the concept of entopy: does allergy exist in nonallergic rhinitis?
TL;DR: The concept of local allergy in IR patients is both intriguing and controversial, and currently there is no single best test to evaluate for entopy, which has been coined entopy.
Journal ArticleDOI
Imported fire ant field reaction and immunotherapy safety characteristics: The IFACS study
TL;DR: IFA SCIT is safe; however, having an SR to skin testing or the presence of large local reactions increases the odds of having anSR to IFASCIT.
Journal ArticleDOI
The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
TL;DR: In a clinic that does not dose-adjust for local reactions, local reactions do not predict local reactions at the next immunotherapy injection.